Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study

Cerebral Cortex

Volumn 27, Issue 1, 2017, Pages 400-410

  Salvesen, Lisette ^a,b,c   Winge, Kristian ^b,c   Brudek, Tomasz ^a   Agander, Tina Klitmøller ^d   Løkkegaard, Annemette ^c   Pakkenberg, Bente ^a  

^a Research Laboratory for Stereology and Neuroscience

^b Bispebjerg Movement Disorders Biobank ^*

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

glial cells; multiple system atrophy; neocortex; neurons; stereology

Indexed keywords

AGED; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOCORTEX; PATHOLOGY; SHY DRAGER SYNDROME;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEOCORTEX;

EID: 85025465992     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhv228     Document Type: Article

References (60)

1. Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL. 2012. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol. 38:4-24.
2. Armstrong RA, Lantos PL, Cairns NJ. 2005. Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex-a study in ten patients. Clin Neuropathol. 24:230-235.
3. Boyce RW, Dorph-Petersen KA, Lyck L, Gundersen HJ. 2010. Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol. 38:1011-1025.
4. Braendgaard H, Evans SM, Howard CV, Gundersen HJ. 1990. The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J Microsc. 157:285-304.
5. Brenneis C, Egger K, Scherfler C, Seppi K, Schocke M, Poewe W, Wenning GK. 2007. Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol. 254:191-196.
6. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, et al. 2010. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 133:2382-2393.
7. Chang CC, Chang YY, Chang WN, Lee YC, Wang YL, Lui CC, HuangCW, Liu WL. 2009. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol. 16:1144-1150.
8. Dubois B, Slachevsky A, Litvan I, Pillon B. 2000. The FAB: a Frontal Assessment Battery at bedside. Neurology. 55:1621-1626.
9. Fabricius K, Jacobsen JS, Pakkenberg B. 2013. Effect of age on neocortical brain cells in 90+ year old human females-a cell counting study. Neurobiol Aging. 34:91-99.
10. Fabricius K, Pakkenberg H, Pakkenberg B. 2007. No changes in neocortical cell volumes or glial cell numbers in chronic alcoholic subjects compared to control subjects. Alcohol Alcohol. 42:400-406.
11. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:189-198.
12. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, et al. 2008. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 71:670-676.
13. Gredal O, Pakkenberg H, Karlsborg M, Pakkenberg B. 2000. Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study. J Neurosci Methods. 15:171-176.
14. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, et al. 1988. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:857-881.
15. Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 147:229-263.
16. Gundersen HJ, Jensen EB, Kieu K, Nielsen J. 1999. The efficiency of systematic sampling in stereology-reconsidered. J Microsc. 193:199-211.
17. Gundersen HJ, Osterby R. 1981. Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. J Microsc. 121:65-73.
18. Halliday GM, Holton JL, Revesz T, Dickson DW. 2011. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 122:187-204.
19. Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, Goto A, Ito Y. 2000. Cerebral atrophy in multiple system atrophy by MRI. J Neurol Sci. 173:109-112.
20. Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M. 1997. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol. 93:585-591.
21. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T. 2004. Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol. 63:43-52.
22. Jellinger KA. 2014. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord. 29:1720-1741.
23. Karlsen AS, Korbo S, Uylings HB, Pakkenberg B. 2014. A stereological study of the mediodorsal thalamic nucleus in Down syndrome. Neuroscience. 279C:253-259.
24. Karlsen AS, Pakkenberg B. 2011. Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with Down syndrome-a stereological study. Cereb Cortex. 21:2519-2524.
25. Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, Kato K, Fukatsu H, Naganawa S, Kato T, et al. 2008. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology. 70:1390-1396.
26. Kim JS, Youn J, Yang JJ, Lee DK, Lee JM, Kim ST, Kim HT, Cho JW. 2013. Topographic distribution of cortical thinning in subtypes of multiple system atrophy. Parkinsonism Relat Disord. 19:970-974.
27. Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, et al. 2008. Red flags for multiple system atrophy. Mov Disord. 23:1093-1099.
28. Konagaya M, Konagaya Y, Sakai M, Matsuoka Y, Hashizume Y. 2002. Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci. 195:123-127.
29. Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Hashizume Y. 1999. Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol. 97:423-428.
30. Korzhevskii DE, Otellin VA, Grigor'ev IP. 2005. Glial fibrillary acidic protein in astrocytes in the human neocortex. Neurosci Behav Physiol. 35:789-792.
31. Lyck L, Dalmau I, Chemnitz J, Finsen B, Schrøder HD. 2008. Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex. J Histochem Cytochem. 56:201-221.
32. Mattis S. 1976. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, editors. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians. New York: Grune & Stratton Inc. p. 77-121.
33. Minnerop M, Specht K, Ruhlmann J, Schimke N, Abele M, Weyer A, Wullner U, Klockgether T. 2007. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage. 36:1086-1095.
34. Mochizuki Y, Mizutani T, Warabi Y, Shimizu T, Isozaki E. 2008. The somatosensory cortex in multiple system atrophy. J Neurol Sci. 271:174-179.
35. Pakkenberg B. 1993. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry. 1:768-772.
36. Papp MI, Kahn JE, Lantos PL. 1989. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 94:79-100.
37. Papp MI, Lantos PL. 1994. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain. 117:235-243.
38. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. 2006. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord. 21:989-996.
39. Pedersen KM, Marner L, Pakkenberg H, Pakkenberg B. 2005. No global loss of neocortical neurons in Parkinson's disease: a quantitative stereological study. Mov Disord. 20:164-171.
40. Pelvig DP, Pakkenberg H, Regeur L, Oster S, Pakkenberg B. 2003. Neocortical glial cell numbers in Alzheimer's disease.Astereological study. Dement Geriatr Cogn Disord. 16:212-219.
41. Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B. 2008. Neocortical glial cell numbers in human brains. Neurobiol Aging. 29:1754-1762.
42. PfafflMW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
43. Pirogovsky E, Schiehser DM, Litvan I, Obtera KM, Burke MM, Lessig SL, Song DD, Liu L, Filoteo JV. 2014. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment. Parkinsonism Relat Disord. 20:627-631.
44. Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B. 1994. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging. 15:347-352.
45. Salvesen L, Ullerup BH, Sunay FB, Brudek T, Løkkegaard A, Agander TK, Winge K, Pakkenberg B. 2015. Changes in total cell numbers of the basal ganglia in patients withmultiple system atrophy - a stereological study. Neurobiol Dis. 74:104-113.
46. Sigaard RK, Kjaer M, Pakkenberg B. 201 . Development of the Cell Population in the Brain White Matter of Young Children. Cereb Cortex.
47. Stokholm J, Vogel A, Johannsen P, Waldemar G. 2009. Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic. Dement Geriatr Cogn Disord. 27:361-365.
48. Su M, Yoshida Y, Hirata Y, Watahiki Y, Nagata K. 2001. Primary involvement of themotor area in association with the nigrostriatal pathway inmultiple systematrophy: neuropathological and morphometric evaluations. Acta Neuropathol. 101:57-64.
49. Trojanowski JQ, Revesz T. 2007. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol. 33:615-620.
50. Tsuchiya K, Ozawa E, Haga C, Watabiki S, Ikeda M, Sano M, Ooe K, Taki K, Ikeda K. 2000. Constant involvement of the Betz cells and pyramidal tract in multiple system atrophy: a clinicopathological study of seven autopsy cases. Acta Neuropathol. 99:628-636.
51. Uylings HB, van Eden CG, Hofman MA. 1986. Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions. J Neurosci Methods. 18:19-37.
52. Wakabayashi K, Takahashi H. 2006. Cellular pathology in multiple system atrophy. Neuropathology. 26:338-345.
53. Walloe S, Pakkenberg B, Fabricius K. 2014. Stereological estimation of total cell numbers in the human cerebral and cerebellar cortex. Front Hum Neurosci. 8:508.
54. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. 2000. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry. 68:434-440.
55. Wenning GK, Krismer F. 2013. Multiple system atrophy. Handb Clin Neurol. 117:229-241.
56. WenningGK, StefanovaN, JellingerKA, PoeweW, SchlossmacherMG. 2008. Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol. 64:239-246.
57. Wenning GK, Tison F, Ben SY, Daniel SE, Quinn NP. 1997. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 12:133-147.
58. West MJ. 2012. Introduction to stereology. Cold Spring Harb Protoc. 2012:pii: pdb.top070623.
59. Yoshida M. 2007. Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology. 27:484-493.
60. Zilles K, Amunts K. 2012. Architecture of the Cerebral Cortex. In: Mai JK, Paxinos G, editors. The human nervous system. 3rd ed. Amsterdam (Netherlands): Academic Press. p. 836-895.